The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter

Vilazodone (VLZ) is a drug for the treatment of major depressive disorders that targets the serotonin transporter (SERT). Here, the authors combine pharmacology measurements and cryo-EM structural analysis to characterize VLZ binding to SERT and observe that VLZ exhibits non-competitive inhibition o...

Full description

Bibliographic Details
Main Authors: Per Plenge, Dongxue Yang, Kristine Salomon, Louise Laursen, Iris E. Kalenderoglou, Amy H. Newman, Eric Gouaux, Jonathan A. Coleman, Claus J. Loland
Format: Article
Language:English
Published: Nature Publishing Group 2021-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-25363-3
id doaj-7e4dd1b8938f4697aed6a531fb670e57
record_format Article
spelling doaj-7e4dd1b8938f4697aed6a531fb670e572021-08-22T11:38:57ZengNature Publishing GroupNature Communications2041-17232021-08-0112111210.1038/s41467-021-25363-3The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporterPer Plenge0Dongxue Yang1Kristine Salomon2Louise Laursen3Iris E. Kalenderoglou4Amy H. Newman5Eric Gouaux6Jonathan A. Coleman7Claus J. Loland8Laboratory for Membrane Protein Dynamics. Department of Neuroscience, Faculty of Health and Medical Sciences, University of CopenhagenVollum Institute, Oregon Health & Science UniversityLaboratory for Membrane Protein Dynamics. Department of Neuroscience, Faculty of Health and Medical Sciences, University of CopenhagenLaboratory for Membrane Protein Dynamics. Department of Neuroscience, Faculty of Health and Medical Sciences, University of CopenhagenLaboratory for Membrane Protein Dynamics. Department of Neuroscience, Faculty of Health and Medical Sciences, University of CopenhagenMedicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of HealthVollum Institute, Oregon Health & Science UniversityVollum Institute, Oregon Health & Science UniversityLaboratory for Membrane Protein Dynamics. Department of Neuroscience, Faculty of Health and Medical Sciences, University of CopenhagenVilazodone (VLZ) is a drug for the treatment of major depressive disorders that targets the serotonin transporter (SERT). Here, the authors combine pharmacology measurements and cryo-EM structural analysis to characterize VLZ binding to SERT and observe that VLZ exhibits non-competitive inhibition of serotonin transport and binds with nanomolar affinity to an allosteric site in SERT.https://doi.org/10.1038/s41467-021-25363-3
collection DOAJ
language English
format Article
sources DOAJ
author Per Plenge
Dongxue Yang
Kristine Salomon
Louise Laursen
Iris E. Kalenderoglou
Amy H. Newman
Eric Gouaux
Jonathan A. Coleman
Claus J. Loland
spellingShingle Per Plenge
Dongxue Yang
Kristine Salomon
Louise Laursen
Iris E. Kalenderoglou
Amy H. Newman
Eric Gouaux
Jonathan A. Coleman
Claus J. Loland
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
Nature Communications
author_facet Per Plenge
Dongxue Yang
Kristine Salomon
Louise Laursen
Iris E. Kalenderoglou
Amy H. Newman
Eric Gouaux
Jonathan A. Coleman
Claus J. Loland
author_sort Per Plenge
title The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
title_short The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
title_full The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
title_fullStr The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
title_full_unstemmed The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
title_sort antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2021-08-01
description Vilazodone (VLZ) is a drug for the treatment of major depressive disorders that targets the serotonin transporter (SERT). Here, the authors combine pharmacology measurements and cryo-EM structural analysis to characterize VLZ binding to SERT and observe that VLZ exhibits non-competitive inhibition of serotonin transport and binds with nanomolar affinity to an allosteric site in SERT.
url https://doi.org/10.1038/s41467-021-25363-3
work_keys_str_mv AT perplenge theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT dongxueyang theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT kristinesalomon theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT louiselaursen theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT irisekalenderoglou theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT amyhnewman theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT ericgouaux theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT jonathanacoleman theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT clausjloland theantidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT perplenge antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT dongxueyang antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT kristinesalomon antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT louiselaursen antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT irisekalenderoglou antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT amyhnewman antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT ericgouaux antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT jonathanacoleman antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
AT clausjloland antidepressantdrugvilazodoneisanallostericinhibitoroftheserotonintransporter
_version_ 1721199548339060736